Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234. [electronic resource]
Producer: 20190528Description: 4067-4086 p. digitalISSN:- 1520-4804
- Animals
- Azabicyclo Compounds -- chemistry
- Bridged Bicyclo Compounds -- chemistry
- Cyclooctanes -- chemistry
- Drug Synergism
- Gram-Negative Bacteria -- drug effects
- Lung -- drug effects
- Mice
- Octanes -- chemistry
- Peritonitis -- drug therapy
- Piperidines -- chemistry
- beta-Lactam Resistance -- drug effects
- beta-Lactamase Inhibitors -- chemistry
- beta-Lactamases -- metabolism
- beta-Lactams -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.